Tyler, thanks for your ACTC...
update. :) ACTC is one of the Stem-cell stocks that I follow in addition to CBAI,STEM, PSTI, NBS, CUR, and ASTM among others. ACTC was supposed to do an RS but I haven't seen any evidence of this. Do you think they will do an RS? What do you think of their large OS; is this a potential problem in your opinion? ACTC's numerous patents and clinical trials are impressive.
Best,
Bob